Alpini G, Glaser S S, Ueno Y, Pham L, Podila P V, Caligiuri A, LeSage G, LaRusso N F
Department of Medical Physiology and Internal Medicine, Scott & White Hospital, Temple, Texas, USA.
Am J Physiol. 1998 Apr;274(4):G767-75. doi: 10.1152/ajpgi.1998.274.4.G767.
We previously introduced the concept that intrahepatic bile duct epithelial cells, or cholangiocytes, are functionally heterogeneous. This concept is based on the observation that secretin receptor (SR) gene expression and secretin-induced cAMP synthesis are present in cholangiocytes derived from large (> 15 microns in diameter) but not small (< 15 microns in diameter) bile ducts. In work reported here, we tested the hypothesis that cholangiocytes are heterogeneous with regard to proliferative capacity. We assessed cholangiocyte proliferation in vivo by measurement of [3H]thymidine incorporation and in vitro by both [3H]thymidine incorporation and H3 histone gene expression in small (fraction 1) and large (fraction 2) cholangiocytes isolated from rats after bile duct ligation (BDL). In the two cholangiocyte subpopulations, we also studied basal somatostatin receptor (SSTR2) gene expression as well as the effects of somatostatin on 1) SR gene expression and secretin-induced cAMP synthesis and 2) [3H]thymidine incorporation and H3 histone gene expression. In normal rat liver, cholangiocytes, unlike hepatocytes, were mitotically dormant; after BDL, incorporation of [3H]thymidine markedly increased in cholangiocytes but not hepatocytes. When subpopulations of cholangiocytes were isolated after BDL, DNA synthesis assessed by both techniques was limited to large cholangiocytes, as was SSTR2 steady-state gene expression. In vitro, somatostatin inhibited SR gene expression and secretin-induced cAMP synthesis only in large cholangiocytes. Moreover, compared with no hormone, somatostatin inhibited DNA synthesis solely in large cholangiocytes. These results support the concept of the heterogeneity of cholangiocytes along the biliary tree, extend this concept to cholangiocyte proliferative activity, and imply that the proliferative compartment of cholangiocytes after BDL is located principally in the cholangiocytes lining large (> 15 microns) bile ducts.
我们之前提出了肝内胆管上皮细胞(即胆管细胞)功能具有异质性的概念。这一概念基于以下观察结果:促胰液素受体(SR)基因表达以及促胰液素诱导的cAMP合成存在于源自大(直径>15微米)而非小(直径<15微米)胆管的胆管细胞中。在本文报道的研究中,我们检验了胆管细胞在增殖能力方面具有异质性的假说。我们通过测量[3H]胸腺嘧啶核苷掺入来评估体内胆管细胞的增殖,通过[3H]胸腺嘧啶核苷掺入以及H3组蛋白基因表达来评估体外胆管细胞的增殖,这些胆管细胞来自胆管结扎(BDL)后的大鼠,分为小胆管细胞(组分1)和大胆管细胞(组分2)。在这两个胆管细胞亚群中,我们还研究了基础生长抑素受体(SSTR2)基因表达以及生长抑素对以下方面的影响:1)SR基因表达和促胰液素诱导的cAMP合成,以及2)[3H]胸腺嘧啶核苷掺入和H3组蛋白基因表达。在正常大鼠肝脏中,与肝细胞不同,胆管细胞处于有丝分裂静止状态;BDL后,胆管细胞中[3H]胸腺嘧啶核苷的掺入显著增加,而肝细胞中则没有。BDL后分离出胆管细胞亚群时,两种技术评估的DNA合成均仅限于大胆管细胞,SSTR2稳态基因表达也是如此。在体外,生长抑素仅在大胆管细胞中抑制SR基因表达和促胰液素诱导的cAMP合成。此外,与无激素作用相比,生长抑素仅在大胆管细胞中抑制DNA合成。这些结果支持了沿胆管树胆管细胞具有异质性的概念,将这一概念扩展至胆管细胞的增殖活性,并表明BDL后胆管细胞的增殖部分主要位于内衬大(>15微米)胆管的胆管细胞中。